47 results on '"Perrone MP"'
Search Results
2. D partial, D weak: confronto test sierologici e analisi molecolare
- Author
-
Coluzzi, S, DE NICOLÒ, C, Perrone, Mp, Laurenti, L, Giambelli, L, Ferruzzi, I, Farinelli, M, Neri, A, Arista, Maria Cristina, Gesuiti, P, Vaglio, Stefania, Farina, B, Recchia, L, and Girelli, Gabriella
- Published
- 2010
3. Esperienza pluriennale nell’applicazione della biologia molecolare per lo studio delle varianti del gene RHD
- Author
-
Perrone, Mp, Laurenti, L, Gesuiti, P, Arista, Mc, Coluzzi, S, DE NICOLÒ, C, Farina, B, Recchia, L, Rossetto, Gerardo, Vaglio, Stefania, and Girelli, Gabriella
- Published
- 2010
4. Early impairment of HCV-specific T-cell proliferation during acute HCV infection leads to failure of viral clearance
- Author
-
Folgori, A, Spada, E, Pezzanera, M, Ruggeri, L, Mele, A, Garbuglia, Ar, Perrone, Mp, DEL PORTO, Paola, Piccolella, Enza, Cortese, R, Nicosia, A, and Vitelli, A.
- Published
- 2006
5. Anemia emolitica autoimmune con specificità anti-Jka
- Author
-
Vaglio, Stefania, Perrone, Mp, Arista, Maria Cristina, Laurenti, L, Screnci, M, Pasqualetti, Daniela, DE NICOLÒ, C, and Girelli, Gabriella
- Published
- 2004
6. RhD variant: metodiche a confronto
- Author
-
Vaglio, Stefania, Perrone, Mp, Arista, Mc, Pasqualetti, Daniela, Laurenti, L, Rosato, V, Giambelli, L, Tomei, Gabriella, Rago, Angela, and Girelli, Gabriella
- Published
- 2003
7. Interferenza nella determinazione ABO su colonna in due casi di MEN da incompatibilità Rh
- Author
-
Vaglio, Stefania, Ferrazza, G, Perrone, Mp, Carboni, C, Arista, Mc, and Girelli, G.
- Published
- 2002
8. Search for unrelated cord blood (CB) unit for transplantation of high risk leukemic patients
- Author
-
Screnci, M, Carmini, D, Iori, Ap, Guglielmi, Cesare, Testi, Anna Maria, Cimino, Giuseppe, Elia, L, Perrone, Mp, Laurenti, L, De felice, L, and Arcese, William
- Published
- 1998
9. Ricerca di unità di sangue di cordone ombellicale (SCO) da donatore non correlato per trapianto allogenico in pazienti affetti da leucemia ad alto rischio
- Author
-
Carmini, D, Screnci, M, Iori, Ap, Vulcano, F, Guglielmi, Cesare, Mengarelli, A, Testi, Anna Maria, Cimino, Giuseppe, Elia, L, Perrone, Mp, Laurenti, L, De Felice, L, and Arcese, William
- Published
- 1997
10. HLA TYPING IN HAIRY-CELL LEUKEMIA (HCL) - REPORT OF A FAMILIAL HCL AND AN ASSOCIATION OF HCL WITH CHRONIC LYMPHOCYTIC-LEUKEMIA
- Author
-
Ferrari, A, Annino, L, Perrone, Mp, Laurenti, L, Mauro, Francesca Romana, Girelli, Gabriella, and Mandelli, Franco
- Published
- 1993
11. Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8(+) T cell response
- Author
-
Santodonato, L., D Agostino, G., Nisini, R., Mariotti, S., Monque, Dm, Spada, M., Lattanzi, L., Perrone, Mp, mauro andreotti, Belardelli, F., and Ferrantini, M.
12. Role of killer inhibitory receptors (KIRs) in HHV8 infection and KS development
- Author
-
Sirianni, Mc, Libi, F., Campagna, M., Turchi, F., Laurenti, L., Perrone, Mp, Monini, P., and Barbara Ensoli
13. Histopathological and molecular features of persistent polyclonal B-cell lymphocytosis (PPBL) with progressive splenomegaly
- Author
-
Robin Foà, Francesca Romana Mauro, Daniele Armiento, Elena Sabattini, Francesca Mancini, Paola Gesuiti, Luisa Quattrocchi, Irene Della Starza, Ilaria Del Giudice, Maria Stefania De Propris, Maura Rossi, Maria Paola Perrone, Stefano Pileri, Angela Amendola, Cristina Campidelli, Agostino Tafuri, Anna Guarini, Del Giudice I, Pileri SA, Rossi M, Sabattini E, Campidelli C, Starza ID, De Propris MS, Mancini F, Perrone MP, Gesuiti P, Armiento D, Quattrocchi L, Tafuri A, Amendola A, Mauro FR, Guarini A, and Foà R.
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,Lymphocytosis ,Adolescent ,histopathology ,lymphoproliferative disease ,mzl ,ppbl ,splenectomy ,Immunoglobulin D ,Polymerase Chain Reaction ,Immunophenotyping ,Young Adult ,immune system diseases ,Bone Marrow ,medicine ,Humans ,Lymphocyte Count ,Gene Rearrangement ,B-Lymphocytes ,biology ,business.industry ,Smoking ,Hematology ,HLA-DR Antigens ,medicine.disease ,CD79A ,Lymphoma ,medicine.anatomical_structure ,Proto-Oncogene Proteins c-bcl-2 ,Splenomegaly ,biology.protein ,Red pulp ,Splenectomy ,Female ,Bone marrow ,Splenic disease ,medicine.symptom ,business ,Immunoglobulin Heavy Chains ,Spleen ,Follow-Up Studies ,HLA-DRB1 Chains - Abstract
Five cases of persistent polyclonal B-cell lymphocytosis (PPBL) with progressive splenomegaly are reported; three were splenectomized. BCL2/ IGH rearrangements were found in three cases; HLA-DRB1*07 in all. Bone marrow (BM) trephines showed a moderate lymphoid infiltrate with intrasinusoidal distribution resembling a splenic marginal-zone lymphoma. Splenic white pulp revealed an enlargement of the marginal-zone area; red pulp was infiltrated by the same lymphocytes engulfing the sinuses. Splenic and BM B-lymphocytes were CD79a + /CD20 + /IgM + /IgD + /bcl-2 + /CD27 + / DBA.44 - /CD31 - and polyclonal by immunophenotype/polymerase chain reaction. PPBL features an expansion of splenic marginal-zone B-lymphocytes, which infiltrate BM sinusoids and circulate in the blood with no evidence of clonality, even in cases with progressive splenomegaly.
- Published
- 2009
14. Donor specific anti-HLA antibodies in hematopoietic stem cell transplantation. Single Center prospective evaluation and desensitization strategies employed.
- Author
-
La Rocca U, Perrone MP, Piciocchi A, Barberi W, Gesuiti P, Laurenti L, Cinti P, Gozzer M, Bafti MS, Carmini D, Cinelli N, Cavallari C, Giovannetti G, Ricci R, Girelli G, Foà R, Martelli M, Coluzzi S, and Iori AP
- Subjects
- Humans, Female, Prospective Studies, Tissue Donors, Immunoglobulins, Intravenous, HLA Antigens, Graft Rejection prevention & control, Histocompatibility Testing, Retrospective Studies, Hematopoietic Stem Cell Transplantation
- Abstract
Background: In the setting of mismatched-hematopoietic stem cells transplantation, the detection of antibodies directed against donor-specific HLA allele(s) or antigen(s) (DSA) represents a barrier for engraftment. It is thus necessary to plan an immunosuppressive strategy, or to select an alternative donor. This prospective study aimed at evaluating the efficacy of our strategy for testing DSAs and the efficacy of the desensitization strategy (DS) employed between November 2017 and November 2020., Materials and Methods: The anti-HLA antibody search was performed using the Luminex bead assays (Lifecode ID and LSA I/II-Immucor) and expressed as mean fluorescence intensity (MFI >1,000 positive). If the patient had DSAs and no alternative donors, a DS was employed with rituximab (day -15), 2 single volume plasmaphereses (PP; days -9 and -8), intravenous immunoglobulins (day -7) and infusion of HLA selected platelets, if persistent DSAs were directed against class I HLA. DS was scheduled with or without PP, according to the DSA MFI (>1,000 or <5,000) and FCXM (flow cytometry crossmatch)., Results: Twenty-two out of 126 patients (17.46%) showed anti-HLA antibodies, 5 of them DSAs (3.97% of total); 3 patients underwent DS obtaining engraftment. Female gender (p=0.033) and a history of previous pregnancies or miscarriages (p=0.009) showed a statistically significant impact on alloimmunization. Factors associated with a delayed neutrophil engraftment were patient's female gender (p=0.039), stem cell source (p=0.025), and a high HSCT-specific comorbidity index (p=0.028). None of the analyzed variables, including the DSA detection, influenced engraftment., Conclusions: Our study confirms the importance to test DSAs in mismatched-hematopoietic stem cells transplantation The DS used proved successful in removing DSAs. Prospective multicenter studies are needed to better define and validate consensus strategies on DSA management in HSCT.
- Published
- 2024
- Full Text
- View/download PDF
15. Effect of Cosmos, Crotalaria, Foeniculum, and Canavalia species, single-cropped or mixes, on the community of predatory arthropods.
- Author
-
Barros AP, de Carvalho Silva A, de Souza Abboud AC, Ricalde MP, and Ataide JO
- Subjects
- Animals, Canavalia, Plants, Predatory Behavior, Sulfur, Arthropods, Asteraceae, Crotalaria, Foeniculum
- Abstract
Some plants can attract natural enemy by offering resources such as alternative food and refuge. However, studies need to be conducted before agricultural landscape diversification is implement. Our objective was to determine the best floristic compositions of cosmos (Cosmos sulphureus-Asteraceae), showy rattlepod (Crotalaria spectabilis-Fabaceae), fennel (Foeniculum vulgare-Apiaceae), and jack bean (Canavalia ensiformis-Fabaceae) to attract and maintain predatory arthropods, and know the potential of these treatments for future use in diversifying agricultural systems. The experimental design consisted in seven treatments of four species in single-crop, intercrops in three densities called mix1, mix2, and mix3, and the control (weeds). For the arthropod families classified as very frequent and constant, population dynamics in intercropping treatments was plotted according to the plant phenology. We conclude that all plants cultivated in single-cropping and intercropping treatments showed high predator richness and can potentially be used to diversify cultivated areas. Sulfur cosmos as a single crop and three mixes attracts higher numbers and greater family richness. Spider families-Oxyopidae, Araneidae and Thomisidae-and insects-Chrysopidae and Coccinellidae are more frequents. The dynamics of the predator populations varied according to the mixes treatment., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
16. SARS-COV-2 vaccination with BNT162B2 in renal transplant patients: Risk factors for impaired response and immunological implications.
- Author
-
Russo G, Lai Q, Poli L, Perrone MP, Gaeta A, Rossi M, Mastroianni CM, Garofalo M, and Pretagostini R
- Subjects
- Antibodies, Viral, BNT162 Vaccine, COVID-19 Vaccines, Humans, Middle Aged, Risk Factors, SARS-CoV-2, Seroepidemiologic Studies, Vaccination, COVID-19, Kidney Transplantation
- Abstract
Solid organ transplant patients are at a higher risk for poor CoronaVirus Disease-2019 (COVID-19)-related outcomes and have been included as a priority group in the vaccination strategy worldwide. We assessed the safety and efficacy of a two-dose vaccination cycle with mRNA-based COVID-19 vaccine (BNT162b2) among 82 kidney transplant outpatients followed in our center in Rome, Italy. After a median of 43 post-vaccine days, a SARS-CoV-2 anti-Spike seroprevalence of 52.4% (n = 43/82) was observed. No impact of the vaccination on antibody-mediated rejection or graft function was observed, and no significant safety concerns were reported. Moreover, no de novo HLA-donor-specific antibodies (DSA) were detected during the follow-up period. Only one patient with pre-vaccination HLA-DSA did not experience an increased intensity of the existing HLA-DSA. During the follow-up, only one infection (mild COVID-19) was observed in a patient after receiving the first vaccine dose. According to the multivariable logistic regression analysis, lack of seroconversion after two-dose vaccination independently associated with patient age ≥60 years (OR = 4.50; P = .02) and use of anti-metabolite as an immunosuppressant drug (OR = 5.26; P = .004). Among younger patients not taking anti-metabolites, the seroconversion rate was high (92.9%). Further larger studies are needed to assess the best COVID-19 vaccination strategy in transplanted patients., (© 2021 The Authors. Clinical Transplantation published by John Wiley & Sons Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
17. Anti-HLA donor-specific antibodies in allogeneic stem cell transplantation: management and desensitization protocol.
- Author
-
La Rocca U, Perrone MP, Piciocchi A, Cinti P, Barberi W, Gozzer M, Baftii MS, Torelli GF, Quattrocchi L, Gesuiti P, Lattanzi R, Cavallari C, Ricci R, Laurenti L, Foà R, Girelli G, and Iori AP
- Subjects
- Adolescent, Adult, Aged, Child, Child, Preschool, Female, Hematopoietic Stem Cell Transplantation, Humans, Male, Middle Aged, Young Adult, Desensitization, Immunologic methods, HLA Antigens immunology, Transplantation Conditioning methods, Transplantation, Homologous methods
- Published
- 2019
- Full Text
- View/download PDF
18. Identification of a novel HLA-DPB1 allele, DPB1*138:01, by sequence-based typing.
- Author
-
Perrone MP, Andreani M, Gesuiti P, Condello R, and Testi M
- Subjects
- Alleles, Base Sequence, Chromosomes, Human, Pair 6, Exons, HLA-DP beta-Chains immunology, Hematopoietic Stem Cell Transplantation, Histocompatibility Testing, Humans, Molecular Sequence Data, Sequence Alignment, Sequence Analysis, DNA, Tissue Donors, HLA-DP beta-Chains genetics, Polymorphism, Single Nucleotide
- Abstract
The new allele differs from HLA-DPB1*23:01 in exon 3., (© 2012 John Wiley & Sons A/S.)
- Published
- 2012
- Full Text
- View/download PDF
19. Concurrent search for unrelated cord and volunteer donor in high-risk acute lymphoblastic leukemia.
- Author
-
Iori AP, Valle V, Piciocchi A, Meloni G, Torelli GF, Vitale A, Testi AM, Barberi W, Ricci R, Milano F, Lucarelli B, Screnci M, Perrone MP, Laurenti L, Natalino F, Perrone S, Sacchi N, Arcese W, and Foà R
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Female, Fetal Blood cytology, Humans, Infant, Male, Middle Aged, Precursor Cell Lymphoblastic Leukemia-Lymphoma epidemiology, Precursor Cell Lymphoblastic Leukemia-Lymphoma mortality, Recurrence, Remission Induction, Risk Factors, Survival Analysis, Volunteers, Young Adult, Blood Donors, Histocompatibility Testing methods, Histocompatibility Testing statistics & numerical data, Precursor Cell Lymphoblastic Leukemia-Lymphoma immunology, Precursor Cell Lymphoblastic Leukemia-Lymphoma therapy, Unrelated Donors
- Abstract
To assess the effectiveness of the search for an unrelated donor on the outcome of patients with high-risk acute lymphoblastic leukemia, we analyzed prospectively 136 patients who underwent a search for cord blood (CB) and an unrelated volunteer donor (UD) at the same time. The probability of finding a donor was 58.2%, 70.3%, and 75.7% at 3, 6, and 12 months, respectively. The median time to find a donor was 1.8 months for CB and 3.5 months for UD. Of the 99 patients with a donor, 38.4% failed to undergo the transplant because of a relapse observed at a median of 4 months from the start of the search. In univariate analysis, absence of relapse during the search (p < 0.0001) and transplant (p = 0.004) showed a positive impact on long-term survival. In multivariate analysis, relapse during the search remained the key factor affecting survival (p < 0.0001). Since an extension of the search beyond 3 months enables only a slight increase in the probability of finding a donor compared to the increased risk of relapse, the time of the search should not exceed the 3-month time point. The simultaneous search for CB and UD increases the likelihood of performing a timely transplant.
- Published
- 2012
- Full Text
- View/download PDF
20. Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study.
- Author
-
Zuliani G, Donnorso MP, Bosi C, Passaro A, Dalla Nora E, Zurlo A, Bonetti F, Mozzi AF, and Cortese C
- Subjects
- Aged, Atrophy pathology, Biomarkers blood, Brain diagnostic imaging, Brain pathology, C-Reactive Protein metabolism, Case-Control Studies, Cholesterol blood, Cognitive Dysfunction blood, Female, Genotype, Humans, Male, PPAR gamma genetics, Polymorphism, Single Nucleotide, Radiography, Alzheimer Disease blood, Dementia, Vascular blood, Dementia, Vascular genetics, Hydroxycholesterols blood
- Abstract
Background: In central nervous system cholesterol cannot be degraded but is secreted into circulation predominantly in the form of its polar metabolite 24(S)-hydroxycholesterol (24S-OH-Chol). Some studies suggested an association between 24S-OH-Chol metabolism and different neurological diseases including dementia. A possible decrease in 24S-OH-Chol plasma levels has been reported late onset Alzheimer's disease (LOAD) and vascular dementia (VD), but results of previous studies are partially contradictory., Methods: By high-speed liquid chromatography/tandem mass spectrometry we evaluated the plasma levels of 24S-OH-Chol in a sample of 160 older individuals: 60 patients with LOAD, 35 patients with VD, 25 subjects affected by cognitive impairment no-dementia (CIND), and 40 (144 for genetics study) cognitively normal Controls. We also investigated the possible association between PPARgamma Pro12Ala polymorphism and dementia or 24S-OH-Chol levels., Results: Compared with Controls, plasma 24S-OH-Chol levels were higher in LOAD and lower in VD; a slight not-significant increase in CIND was observed (ANOVA p: 0.001). A positive correlation between 24S-OH-Chol/TC ratio and plasma C reactive protein (CRP) levels was found in the whole sample, independent of possible confounders (multiple regression p: 0.04; r2: 0.10). This correlation was strong in LOAD (r: 0.39), still present in CIND (r: 0.20), but was absent in VD patients (r: 0.08). The PPARgamma Pro12Ala polymorphism was not associated with the diagnosis of LOAD, VD, or CIND; no correlation emerged between the Ala allele and 24S-OH-Chol plasma levels., Conclusions: Our results suggest that plasma 24S-OH-Chol levels might be increased in the first stages of LOAD, and this phenomenon might be related with systemic inflammation. The finding of lower 24S-OH-Chol concentrations in VD might be related with a more advanced stage of VD compared with LOAD in our sample, and/or to different pathogenetic mechanisms and evolution of these two forms of dementia.
- Published
- 2011
- Full Text
- View/download PDF
21. [Injuries: preventive approach and progress of injuries in the construction of the line B1 of the underground of Rome].
- Author
-
Saggio G, Conti E, Valentini F, De Sio L, and Capano MP
- Subjects
- Humans, Rome, Accidents, Occupational prevention & control, Accidents, Occupational statistics & numerical data, Facility Design and Construction, Occupational Health, Railroads, Wounds and Injuries epidemiology, Wounds and Injuries prevention & control
- Abstract
The line B1 is a branch of the existing Metro line B in Rome. The route is long about 5 km, is completely underground and involves the construction of four new stations: Annibaliano, Libia /Gondar, Conca d'Oro and Jonio. The line will have a capacity of transport of 24,000 people/hour in each direction. The works started in 2006 involve about 500 workers. The report provides a statistical analysis of the events that occurred in the period 2005/2010 and aims to introduce the starting and management of this study, also on the basis of the "Operating procedures" issued by the acquisition of OSHAS 18001 certification from the agent of Metro B) / R.I.M.A.T.I. This analysis aims to provide to supervisors, to social security institutions and to workers, a usefull analysis tool in the prevention of the monitored events.
- Published
- 2010
22. Prevalence of allo-immunization anti-HLA and anti-integrin alphaIIbbeta3 in Glanzmann Thromboasthenia patients.
- Author
-
Santoro C, Rago A, Biondo F, Conti L, Pulcinelli F, Laurenti L, Perrone MP, Baldacci E, Leporace A, and Mazzucconi MG
- Subjects
- Adult, Aged, Delivery, Obstetric, Enzyme-Linked Immunosorbent Assay, Female, Genotype, Humans, Integrin alpha2 genetics, Integrin beta3 genetics, Male, Middle Aged, Mutation genetics, Phenotype, Pregnancy, Thrombasthenia genetics, Young Adult, HLA Antigens immunology, Isoantibodies analysis, Platelet Glycoprotein GPIIb-IIIa Complex immunology, Platelet Transfusion, Thrombasthenia immunology, Thrombasthenia therapy
- Abstract
Summary: Platelet transfusions, main therapy of Glanzmann Thromboasthenia (GT), can induce an allo-immunization against human leucocyte antigen and integrin alphaIIbbeta3. We have investigated in our GT patients the rate of allo-immunization and of refractoriness to platelet transfusions. From 1975 until December 2005, we have followed 17 GT patients: 14 type 1, 3 variant type; nine females, eight males; median age at diagnosis 9.8 years (range 1-44.5); median age at the time of the study 35.5 years (range 23.6-68.5). In our patients, 121 bleeding episodes occurred (24 severe, 37 moderate, and 60 mild). Ten major and 22 minor surgical procedures have been performed. Two spontaneous deliveries and three caesarian sections with five live births were performed; moreover, one late foetal loss occurred, and one voluntary abortion was performed. Sixteen of 17 patients have been transfused at least once in life with platelets and/or red blood cells (RBC). All transfused patients have been investigated for the presence of anti-HLA and anti-integrin alphaIIbbeta3 allo-antibodies. The positiveness of allo-antibodies has been demonstrated in 4/16 transfused patients (25%): isolated for anti-HLA in two; isolated for anti-integrin alphaIIbbeta3 in one; and combined in one. In spite of the presence of allo-antibodies, platelet transfusions have always been effective and the haemostasis was not compromised.
- Published
- 2010
- Full Text
- View/download PDF
23. Impact of viral selected mutations on T cell mediated immunity in chronically evolving and self limiting acute HCV infection.
- Author
-
Guglietta S, Garbuglia AR, Salichos L, Ruggeri L, Folgori A, Perrone MP, Camperio C, Mellace V, Maio G, Maio P, Capobianchi MR, Spada E, Gargano N, Scottà C, Piccolella E, and Del Porto P
- Subjects
- Adult, Amino Acid Sequence, CD8-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes virology, Epitopes, T-Lymphocyte genetics, Epitopes, T-Lymphocyte immunology, Evolution, Molecular, Female, Genome, Viral, Hepacivirus immunology, Hepatitis C virology, Humans, Immunodominant Epitopes immunology, Male, Middle Aged, Molecular Sequence Data, Mutation, Phylogeny, Sequence Alignment, Sequence Analysis, RNA, T-Lymphocytes, Cytotoxic virology, Viremia immunology, Viremia virology, Hepacivirus genetics, Hepatitis C immunology, Immunity, Cellular, T-Lymphocytes, Cytotoxic immunology
- Abstract
The ability of HCV to mutate in response to cytotoxic T lymphocyte (CTL) pressure is increasingly recognized, but the influence of such a mechanism in viral persistence and final disease outcome has not been ascertained. In this study, we performed a detailed longitudinal analysis of cell mediated immunity and HCV evolution in two self limiting and two chronically evolving HCV acutely infected patients, one of whom transiently controlled viremia. Amino acid mutations in immunodominant regions of viruses were observed in all patients, although they conferred viral escape from CTL responses only in chronically infected individuals. Resurgence of viremia coincided with the replacement of the original virus quasispecies with mutant viruses that had escaped recognition by primary CD8(+) T cell responses and infection persisted in the presence of variant viruses which were less efficiently recognized by preexisting and de novo induced T cell responses.
- Published
- 2009
- Full Text
- View/download PDF
24. Histopathological and molecular features of persistent polyclonal B-cell lymphocytosis (PPBL) with progressive splenomegaly.
- Author
-
Del Giudice I, Pileri SA, Rossi M, Sabattini E, Campidelli C, Starza ID, De Propris MS, Mancini F, Perrone MP, Gesuiti P, Armiento D, Quattrocchi L, Tafuri A, Amendola A, Mauro FR, Guarini A, and Foà R
- Subjects
- Adolescent, Adult, Bone Marrow immunology, Female, Follow-Up Studies, Gene Rearrangement, HLA-DR Antigens analysis, HLA-DRB1 Chains, Humans, Immunoglobulin Heavy Chains genetics, Immunoglobulin Heavy Chains immunology, Immunophenotyping, Lymphocyte Count, Lymphocytosis surgery, Male, Polymerase Chain Reaction, Proto-Oncogene Proteins c-bcl-2 genetics, Proto-Oncogene Proteins c-bcl-2 immunology, Splenectomy, Young Adult, B-Lymphocytes immunology, Lymphocytosis immunology, Smoking immunology, Spleen immunology, Splenomegaly immunology
- Abstract
Five cases of persistent polyclonal B-cell lymphocytosis (PPBL) with progressive splenomegaly are reported; three were splenectomized. BCL2/IGH rearrangements were found in three cases; HLA-DRB1*07 in all. Bone marrow (BM) trephines showed a moderate lymphoid infiltrate with intrasinusoidal distribution resembling a splenic marginal-zone lymphoma. Splenic white pulp revealed an enlargement of the marginal-zone area; red pulp was infiltrated by the same lymphocytes engulfing the sinuses. Splenic and BM B-lymphocytes were CD79a(+)/CD20(+)/IgM(+)/IgD(+)/bcl-2(+)/CD27(+)/DBA.44(-)/CD31(-) and polyclonal by immunophenotype/polymerase chain reaction. PPBL features an expansion of splenic marginal-zone B-lymphocytes, which infiltrate BM sinusoids and circulate in the blood with no evidence of clonality, even in cases with progressive splenomegaly.
- Published
- 2009
- Full Text
- View/download PDF
25. Induction of both CD8+ and CD4+ T-cell-mediated responses in colorectal cancer patients by colon antigen-1.
- Author
-
Maccalli C, Di Cristanziano V, Fodale V, Corsi D, D'Agostino G, Petrangeli V, Laurenti L, Guida S, Mazzocchi A, Arienti F, Perrone MP, Castelli C, Rivoltini L, Zagonel V, Tartaglia M, Parmiani G, and Belardelli F
- Subjects
- Antigen Presentation immunology, Colorectal Neoplasms metabolism, HLA-A Antigens immunology, HLA-A2 Antigen, Humans, Interferon-gamma biosynthesis, Lymphocyte Activation immunology, Antigens, Neoplasm immunology, CD4-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes immunology, Colorectal Neoplasms immunology
- Abstract
Purpose: Colon antigen-1 (COA-1) was recently identified as a novel antigen of colorectal cancer encoded by the UBXD5 gene. Here, we evaluated whether a specific T-cell-mediated response directed against this molecule can occur in colorectal cancer patients., Experimental Design: Antigen- and tumor-specific immunologic responses of peripheral blood mononuclear cells (PBMC) stimulated in vitro with the MHC class II-associated immunogenic epitope of COA-1 (FSTFPPTLYQDDTLTLQAAG) were analyzed by IFN-gamma ELISPOT assay., Results: COA-1-specific and tumor-reactive T lymphocytes were isolated from all (n = 7) HLA-DRbeta1*0402+ or *1301+ colorectal cancer patients with progressive disease (Dukes' C and D) but not in patients (n = 4) with early-stage tumor (Dukes' A and B) and in healthy donors (n = 5), suggesting that the immune response against this antigen is associated with the progression of colorectal cancer. COA-1- and tumor-specific T lymphocytes displayed a CD3+CD4+CD69+CD45RA+ phenotype, compatible with the activated effector-type T-cell subset, and most of them exerted cytotoxic activity against HLA-matched and COA-1+ tumor cells. COA-1-specific T cells could also be isolated by in vitro stimulation of peripheral blood mononuclear cells with autologous dendritic cells loaded with tumor lysate, suggesting that this antigen can generate a dominant immunologic response against colorectal cancer cells. Notably, we could identify also COA-1-derived epitopes binding to HLA-A*0201 molecules that elicited antigen- and tumor-specific CD8+ T-cell-mediated responses in colorectal cancer patients., Conclusions: Both CD4+ and CD8+ T-cell responses against COA-1 can occur in colorectal cancer patients with metastatic disease, suggesting that this antigen is suitable for immunotherapeutic protocols of these patients.
- Published
- 2008
- Full Text
- View/download PDF
26. Influence of specific CD4+ T cells and antibodies on evolution of hypervariable region 1 during acute HCV infection.
- Author
-
Scottà C, Garbuglia AR, Ruggeri L, Spada E, Laurenti L, Perrone MP, Girelli G, Mele A, Capobianchi MR, Folgori A, Nicosia A, Del Porto P, and Piccolella E
- Subjects
- Acute Disease, Adult, Amino Acid Sequence, Evolution, Molecular, Female, Genetic Variation, Humans, Longitudinal Studies, Male, Middle Aged, Molecular Sequence Data, Viral Proteins chemistry, Viral Proteins genetics, CD4-Positive T-Lymphocytes immunology, Hepatitis C immunology, Hepatitis C Antibodies physiology, Viral Proteins immunology
- Abstract
Background/aims: Several studies suggest that the evolutionary rate of HVR1 sequence in acute HCV hepatitis derives from the action of a continuous immune-driven positive selection. However, these studies have not been performed examining the relationship between HVR1 evolution and the development of specific immunity to autologous HVR1 sequences., Methods: We performed a longitudinal analysis of HVR1 sequences and specific antibodies and CD4+ T cells in ten HCV acutely infected patients with different clinical outcomes (recovery versus persistence)., Results: We showed that although both recovered and chronically evolving individuals developed IFN-gamma+ T cells specific for Core and NS sequences, HVR1-specific CD4+ T cells were detected only in patients clearing the virus. On the contrary, all patients displayed anti-HVR1 antibodies that recognized sequences exclusively carried by autologous viruses. Measurements of genetic diversity and the number of non-synonymous per synonymous substitutions within HVR1 sequences before and after antibody appearance showed an increase of these parameters only in concomitance with the appearance of anti-HVR1 antibodies., Conclusions: The evidence that anti-HVR1 antibodies favor HVR1 variant selection suggests that viral complexity in chronically infected patients could represent a virus adaptive strategy to escape the continuous selective process mediated by anti-HVR1 antibodies.
- Published
- 2008
- Full Text
- View/download PDF
27. Unrelated cord blood transplant in children with high-risk acute lymphoblastic leukemia: a long-term follow-up.
- Author
-
Iori AP, Arcese W, Milano F, Calabrese E, Torelli GF, Barberi W, Mascolo MG, De Felice L, Screnci M, Lucarelli B, Malandruccolo L, Perrone MP, Salvatori S, Laurenti L, Iannella E, Ricci R, Moleti ML, and Foà R
- Subjects
- Adolescent, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Blood Cell Count, Child, Child, Preschool, Combined Modality Therapy, Cord Blood Stem Cell Transplantation mortality, Disease-Free Survival, Female, Follow-Up Studies, Graft Survival, Graft vs Host Disease prevention & control, Humans, Immunosuppressive Agents therapeutic use, Male, Postoperative Complications mortality, Precursor Cell Lymphoblastic Leukemia-Lymphoma drug therapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma mortality, Prognosis, Recurrence, Risk, Salvage Therapy, Survival Analysis, Transplantation Conditioning methods, Treatment Outcome, Cord Blood Stem Cell Transplantation statistics & numerical data, Precursor Cell Lymphoblastic Leukemia-Lymphoma surgery, Tissue Donors
- Abstract
Background and Objectives: The aim of this single center study was to assess the impact of pre-transplant factors on long-term follow-up in young patients affected by high-risk acute lymphoblastic leukemia (ALL) who underwent an unrelated cord blood transplant (CBT). The conditioning regimens, graft-versus-host disease (GVHD) prophylaxis and supportive policies were uniform for all patients., Design and Methods: We analyzed the results of CBT performed in 30 patients, aged <18 years, affected by high risk ALL. As conditioning regimen, all patients received 12 Gy fractionated total body irradiation, etoposide, cyclophosphamide and horse anti-lymphocyte globulin. GVHD prophylaxis consisted of 6-methylprednisolone and cyclosporine A. RESULTS The cumulative incidence of engraftment was 93% (95% CI:0.85-0.93). The cumulative incidence of grade III-IV acute and chronic GVHD was 7% (95% CI:0.01-0.19) and 33% (95% CI: 0.17-0.64), respectively. The 9-year cumulative incidence of transplant-related mortality and relapse was 34% (95% CI:0.13-0.45) and 31% (95% CI:0.16-0.61), respectively. The 9-year overall survival, leukemia-free survival and event-free survival were 42% (95% CI:0.52-0.93), 47% (95% CI:0.25-0.61) and 46% (95% CI:0.33-0.61), respectively. A number of CFU-GM <1 x 10(4)/Kg of recipient body weight was the only factor that negatively affected all outcome parameters both in univariate and multivariate analyses., Interpretation and Conclusions: The infused cell dose expressed as in vitro progenitor cell growth represents the most important pre-transplant factor affecting the long-term outcome after an unrelated CBT in young patients with high risk ALL. The number of CFU-GM should thus be considered in the selection process of cord blood units for transplant.
- Published
- 2007
- Full Text
- View/download PDF
28. Autoimmune hemolytic anemia in childhood: serologic features in 100 cases.
- Author
-
Vaglio S, Arista MC, Perrone MP, Tomei G, Testi AM, Coluzzi S, and Girelli G
- Subjects
- Adolescent, Age Distribution, Anemia, Hemolytic, Autoimmune epidemiology, Autoantibodies blood, Child, Child, Preschool, Coombs Test, Erythrocytes metabolism, Hemoglobinuria, Paroxysmal immunology, Humans, Immunoglobulin A blood, Immunoglobulin A immunology, Immunoglobulin G blood, Immunoglobulin G immunology, Incidence, Infant, Isoantibodies blood, Italy epidemiology, Retrospective Studies, Anemia, Hemolytic, Autoimmune immunology
- Abstract
Background: Red blood cell (RBC) autoimmunization is a relatively uncommon cause of anemia in children and presents some differences from those of adults. Due to its frequency, autoimmune hemolytic anemia (AIHA) in childhood has prompted very few studies, and the literature consists mostly of sporadic case histories. The objective of this study was to stress the importance of an appropriate serologic diagnosis in suspected cases., Study Design and Methods: This report describes the immunohematologic features of 100 patients with AIHA studied in the Immunohaematologic Unit of Blood Bank, "La Sapienza" University of Rome. The patients were diagnosed in the same department from 1983 to 2003., Results: The peak incidence of AIHA was in the first 4 years of life. No sex predominance was noted. Warm AIHA was the most common type of acquired immune hemolytic anemia; it comprised 64 of the 100 patients, whereas 26 patients showed a cold AIHA. Associated AIHA showed a slightly more frequent incidence (54/100) compared to idiopathic forms of AIHA (46/100)., Conclusions: In this study serologic records of 100 children with confirmed AIHA are reported. This series, much larger than any previously reported, is critically reviewed and analyzed to delineate the immunologic features of the disease in childhood.
- Published
- 2007
- Full Text
- View/download PDF
29. Anti-D in a D-positive patient: autoantibody or alloantibody?
- Author
-
Vaglio S, Perrone MP, Arista MC, Laurenti L, and Girelli G
- Published
- 2007
- Full Text
- View/download PDF
30. Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance.
- Author
-
Folgori A, Spada E, Pezzanera M, Ruggeri L, Mele A, Garbuglia AR, Perrone MP, Del Porto P, Piccolella E, Cortese R, Nicosia A, and Vitelli A
- Subjects
- Acute Disease, Adult, Antigens, Viral immunology, CD4-Positive T-Lymphocytes immunology, Case-Control Studies, Cell Proliferation, Chi-Square Distribution, Cohort Studies, Female, Hepacivirus genetics, Humans, Interferon-gamma immunology, Interleukin-1 immunology, Male, Middle Aged, RNA, Viral blood, Reverse Transcriptase Polymerase Chain Reaction, Hepacivirus immunology, Hepatitis C immunology, T-Lymphocytes immunology
- Abstract
Background and Aims: Cellular mediated immunity (CMI) is thought to play a key role in resolution of primary hepatitis C virus (HCV) infection. However, CD4+ and CD8+ T cell responses are also generated during acute infection in individuals who become chronic, suggesting that they developed a defective CMI. The aim of this study was to verify if and when such immune dysfunction is established by measuring the breadth, magnitude, function, and duration of CMI in a large cohort of subjects during the natural course of acute HCV infection., Methods: CMI was comprehensively studied by prospective sampling of 31 HCV acutely infected subjects enrolled at the onset of infection and followed for a median period of one year., Results: Our results indicated that while at the onset of acute HCV infection a measurable CMI with effector function was detected in the majority of subjects, after approximately six months less than 10% of chronically infected individuals displayed significant CMI compared with 70% of subjects who cleared the virus. We showed that progressive disappearance of HCV specific T cells from the peripheral blood of chronic patients was due to an impaired ability to proliferate that could be rescued in vitro by concomitant exposure to interleukin 2 and the antigen., Conclusion: Our data provide evidence of strong and multispecific T cell responses with a sustained ability to proliferate in response to antigen stimulation as reliable pharmacodynamic measures of a protective CMI during acute infection, and suggest that early impairment of proliferation may contribute to loss of T cell response and chronic HCV persistence.
- Published
- 2006
- Full Text
- View/download PDF
31. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection.
- Author
-
Guglietta S, Garbuglia AR, Pacciani V, Scottà C, Perrone MP, Laurenti L, Spada E, Mele A, Capobianchi MR, Taliani G, Folgori A, Vitelli A, Ruggeri L, Nicosia A, Piccolella E, and Del Porto P
- Subjects
- Adult, Amino Acid Sequence, CD8-Positive T-Lymphocytes virology, Cytotoxicity Tests, Immunologic, Epitopes, T-Lymphocyte immunology, Evolution, Molecular, Hepacivirus genetics, Hepacivirus immunology, Hepatitis C virology, Humans, Immunodominant Epitopes genetics, Immunodominant Epitopes immunology, Interferon-gamma immunology, Male, Molecular Sequence Data, Peptide Fragments immunology, Sequence Alignment, Sequence Analysis, DNA, T-Lymphocytes, Cytotoxic virology, Viral Nonstructural Proteins genetics, Viral Nonstructural Proteins immunology, Virus Replication genetics, Virus Replication immunology, CD8-Positive T-Lymphocytes immunology, Epitopes, T-Lymphocyte genetics, Hepacivirus physiology, Hepatitis C immunology, T-Lymphocytes, Cytotoxic immunology
- Abstract
Cellular immune responses are induced during hepatitis C virus (HCV) infection and acute-phase CD8+ T cells are supposed to play an important role in controlling viral replication. In chimpanzees, failure of CD8+ T cells to control HCV replication has been associated with acquisition of mutations in MHC class I-restricted epitopes. In humans, although selection of escape mutations in an immunodominant CTL epitope has been recently described, the overall impact of immune escape during acute HCV infection is unclear. Here, by performing an in depth analysis of the relationship between early cellular immune responses and viral evolution in a chronically evolving HCV acutely infected individual, we demonstrate: (i) the presence of a potent and focused CD8(+ T cell response against a novel epitope in the NS3 protein, (ii) the elimination of the quasi-species harboring the original amino acid sequence within this epitope, and (iii) the selection for a virus population bearing amino acid changes at a single residue within the cytotoxic T cell epitope that strongly diminished T cell recognition. These results support the view that acute-phase CD8+ T cell responses exert a biologically relevant pressure on HCV replication and that viruses escaping this host response could have a significant survival advantage.
- Published
- 2005
- Full Text
- View/download PDF
32. Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance.
- Author
-
Spada E, Mele A, Berton A, Ruggeri L, Ferrigno L, Garbuglia AR, Perrone MP, Girelli G, Del Porto P, Piccolella E, Mondelli MU, Amoroso P, Cortese R, Nicosia A, Vitelli A, and Folgori A
- Subjects
- Adult, Alleles, Female, Follow-Up Studies, Genes, MHC Class II, Genetic Predisposition to Disease, HLA-DR Antigens genetics, HLA-DRB1 Chains, Hepatitis C genetics, Hepatitis C virology, Hepatitis C Antibodies blood, Hepatitis C, Chronic genetics, Hepatitis C, Chronic immunology, Histocompatibility Testing, Humans, Immunity, Cellular, Male, Middle Aged, Prognosis, RNA, Viral blood, Remission, Spontaneous, Hepacivirus isolation & purification, Hepatitis C immunology, T-Lymphocytes immunology
- Abstract
Background/aims: Hepatitis C virus (HCV) infection results in a high frequency of chronic disease. The aim of this study was to identify early prognostic markers of disease resolution by performing a comprehensive analysis of viral and host factors during the natural course of acute HCV infection., Methods: The clinical course of acute hepatitis C was determined in 34 consecutive patients. Epidemiological and virological parameters, as well as cell mediated immunity (CMI) and distribution of human leukocyte antigens (HLA) alleles were analysed., Results: Ten out of 34 patients experienced self-limiting infection, with most resolving patients showing fast kinetics of viral clearance: at least one negative HCV RNA test during this phase predicted a favourable outcome. Among other clinical epidemiological parameters measured, the self-limiting course was significantly associated with higher median peak bilirubin levels at the onset of disease, and with the female sex, but only the latter parameter was independently associated after multivariate analysis. No significant differences between self-limiting or chronic course were observed for the distribution of DRB1 and DQB1 alleles. HCV specific T cell response was more frequently detected during acute HCV infection, than in patients with chronic HCV disease. A significantly broader T cell response was found in patients with self-limiting infection than in those with chronic evolving acute hepatitis C., Conclusion: The results suggest that host related factors, in particular sex and CMI, play a crucial role in the spontaneous clearance of this virus. Most importantly, a negative HCV RNA test and broad CMI within the first month after onset of the symptoms represent very efficacious predictors of viral clearance and could thus be used as criteria in selecting candidates for early antiviral treatment.
- Published
- 2004
- Full Text
- View/download PDF
33. Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation.
- Author
-
Iori AP, Cerretti R, De Felice L, Screnci M, Mengarelli A, Romano A, Caniglia M, Cerilli L, Gentile G, Moleti ML, Giona F, Agostini F, Pasqua I, Perrone MP, Pinto MR, Grapulin L, Testi AM, Martino P, De Rossi G, Mandelli F, and Arcese W
- Subjects
- Adolescent, Adult, Cell Count, Child, Child, Preschool, Cord Blood Stem Cell Transplantation adverse effects, Cord Blood Stem Cell Transplantation mortality, Female, Graft Survival, Graft vs Host Disease, Hematopoietic Stem Cells cytology, Humans, Infant, Leukemia diagnosis, Leukemia mortality, Longitudinal Studies, Male, Prognosis, Risk Factors, Survival Analysis, Tissue Donors, Treatment Outcome, Cord Blood Stem Cell Transplantation statistics & numerical data, Leukemia therapy
- Abstract
From July 1995 to December 2001, 42 patients with leukemia aged 1-42 years underwent cord blood transplant (CBT) from unrelated, < or = 2 antigen HLA mismatched donors. In all, 26 patients were in < or = 2nd complete remission and 16 in more advanced phase. Conditioning regimens, graft-versus-host disease (GVHD) prophylaxis and supportive policy were uniform for all patients. The cumulative incidence of engraftment was 90% (95% CI: 0.78-0.91). The cumulative incidence of III-IV grade acute- and chronic-GVHD was 9% (95% CI: 0.04-0.24) and 35% (95% CI: 0.21-0.60), respectively. The 4-year cumulative incidence of transplant-related mortality (TRM) and relapse was 28% (95% CI: 0.17-0.47) and 25% (95% CI: 0.14-0.45), respectively. The 4-year overall survival (OS), leukemia-free survival (LFS) and event-free survival (EFS) were 45% (95% CI: 0.27-0.63), 47% (95% CI: 0.30-0.64) and 46% (95% CI: 0.30-0.62), respectively. In multivariate analysis, the most important factor affecting outcomes was the CFU-GM dose, associated with CMV serology (P=0.003 and 0.04, respectively) in influencing OS and with patient sex (P=0.008 and 0.03, respectively) in influencing LFS. Finally, CFU-GM dose was the only factor that affected EFS significantly (P=0.02). In conclusion, the infused cell dose expressed as in vitro progenitor cell growth is highly predictive of outcomes after an unrelated CBT and should be considered the main parameter in selecting cord blood units for transplant., (Copyright 2004 Nature Publishing Group)
- Published
- 2004
- Full Text
- View/download PDF
34. Production of interferon-gamma by lymphocytes from paroxysmal nocturnal haemoglobinuria patients: relationship with clinical status.
- Author
-
Coluzzi S, Biffoni M, Pasqualetti D, Perrone MP, Vaglio S, Rahimi H, Arista MC, Laurenti L, Cerretti R, and Girelli G
- Subjects
- Adult, Aged, Female, Flow Cytometry, Glycosylphosphatidylinositols metabolism, Histocompatibility Antigens, Humans, Immunophenotyping, Interleukin-2 biosynthesis, Male, Middle Aged, Hemoglobinuria, Paroxysmal immunology, Interferon-gamma biosynthesis, Lymphocytes metabolism
- Abstract
Paroxysmal nocturnal haemoglobinuria (PNH) is characterized by the expansion of phosphatidylinositol glycan class A (PIG-A) defective haematopoietic cells, probably due to the immune-mediated alterations of the bone marrow environment selecting PIG-A- stem cells. The present study investigated the presence of alterations of the immune system in a population of 11 PNH patients. The production of interferon-gamma (IFN-gamma) and interleukin-2 (IL-2), evaluated by intracellular cytokine analysis, and the frequencies of class I and II human leucocyte antigen (HLA) alleles were studied in comparison with healthy human subjects. Similar percentages of lymphocytes produced cytokines in PNH patients and controls after costimulation-independent activation; however, a negative correlation was found between the percentage of IFN-gamma producing cells and white cell or platelets counts. PNH patients showed an higher percentage, compared with controls, of IFN-gamma producing cells after costimulation-dependent activation. The frequency of HLA-A31 was higher in patients than in controls (27.2% vs. 4%), similarly to that of HLA-B7 (27.2% vs. 6%). With regard to class II alleles, 18% of PNH patients expressed DQB1*04 compared with none of 50 control cases. This study supports the hypothesis that immune alteration are present in PNH and that the immunogenetic background could influence the development of the disease.
- Published
- 2004
- Full Text
- View/download PDF
35. Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response.
- Author
-
Santodonato L, D'Agostino G, Nisini R, Mariotti S, Monque DM, Spada M, Lattanzi L, Perrone MP, Andreotti M, Belardelli F, and Ferrantini M
- Subjects
- Animals, CD8-Positive T-Lymphocytes cytology, CD8-Positive T-Lymphocytes transplantation, Cell Culture Techniques methods, Cell Division immunology, Cell Line, Transformed, Cytotoxicity, Immunologic, Dendritic Cells cytology, Dendritic Cells transplantation, Female, Humans, Immunologic Memory immunology, Injections, Intraperitoneal, Lymphocyte Activation immunology, Lymphoma, B-Cell immunology, Lymphoma, B-Cell prevention & control, Mice, Mice, SCID, Monocytes cytology, Peptide Fragments administration & dosage, Peptide Fragments immunology, Peptide Fragments pharmacology, T-Lymphocytes, Cytotoxic immunology, T-Lymphocytes, Cytotoxic virology, CD8-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes virology, Dendritic Cells immunology, Epitopes, T-Lymphocyte immunology, Granulocyte-Macrophage Colony-Stimulating Factor pharmacology, Herpesvirus 4, Human immunology, Interferon-alpha pharmacology, Monocytes immunology
- Abstract
Cellular immune responses are crucial for the control of EBV-associated lymphoproliferative diseases. To induce an anti-EBV cell-mediated immunity, we have used dendritic cells (DCs) generated by a 3-day culture of human CD14(+) monocytes in the presence of GM-CSF and type I IFN (IFN-DCs) and pulsed with peptides corresponding to CTL EBV epitopes. The functional activity of IFN-DCs was compared with that of APCs differentiated by culturing monocytes for 3 days with GM-CSF and IL-4 and indicated as IL-4-DCs. Stimulation of PBLs from EBV-seropositive donors with EBV peptide-pulsed autologous IFN-DCs resulted in a stronger expansion of specific T lymphocytes producing IFN-gamma with respect to stimulation with peptide-loaded IL-4-DCs, as assessed by ELISPOT assays. When purified CD8(+) T cells were cocultured with EBV peptide-pulsed IFN-DCs or IL-4-DCs, significantly higher levels of specific cytotoxic activity were observed in CD8(+) T cell cultures stimulated with IFN-DCs. Injection of peptide-pulsed IFN-DCs into SCID mice transplanted with autologous PBLs led to the recovery of a significantly greater number of EBV-specific human CD8(+) T cells from the spleen and the peritoneal cavity with respect to that recovered from mice injected with peptide-pulsed IL-4-DCs. Moreover, a significant delay in lymphoma development was observed when peptide-pulsed IFN-DCs were injected into SCID mice reconstituted with PBMCs endowed with a high capability of lymphoma induction, whereas injection of unpulsed IFN-DCs was ineffective. Our results indicate that IFN-DCs efficiently promote in vitro and in vivo the expansion of CD8(+) T lymphocytes acting as cytotoxic effectors against EBV-transformed cells.
- Published
- 2003
- Full Text
- View/download PDF
36. HLA typing strategies in a cord blood bank.
- Author
-
Laurenti L, Perrone MP, Bafti MS, Ferrari F, Screnci M, Pasqua I, and Girelli G
- Subjects
- Artifacts, Cell Death, Cross Reactions, DNA Primers, Erythroblasts chemistry, False Positive Reactions, HLA Antigens analysis, HLA-DR Antigens analysis, HLA-DRB1 Chains, Humans, Infant, Newborn, Lymphocytes chemistry, Reproducibility of Results, Sensitivity and Specificity, Serologic Tests, Blood Banks, Cytotoxicity Tests, Immunologic, Fetal Blood cytology, Histocompatibility Testing methods, Polymerase Chain Reaction
- Abstract
Background and Objectives: Although widely used, serological typing of HLA loci does not always produce uequivocal results. This may be particularly the case for cord blood since samples may be of small volume and poor quality, and contaminated., Design and Methods: We typed 220 cord blood units (CBU) for HLA class I antigens using the serological technique. For those samples giving doubtful results we repeated the HLA typing by polymerase chain reaction with sequence specific primers (PCR-SSP)., Results: Results were satisfactory for 181 samples (82.3%). For the remaining 39 (17.7%) we had a doubtful antigen assignment for A locus in 9/39 cases (23.1%) and for B locus in 22/39 cases (56.4%). Eight of the 39 samples (20.5%) could not be analyzed by serology due to the high mortality of the cell suspension. Using PCR-SSP we obtained clear definition of class I antigens in all cases. All CBU were typed for HLA class II alleles by PCR-SSP with clear results in 100% of cases., Interpretation and Conclusions: In our experience, PCR-SSP can resolve the limitations of serology but, at the moment, it cannot substitute the latter in routine practice. The best strategy, in cord blood typing, is to perform both serological and molecular typing in order to obtain an accurate and clear result.
- Published
- 2002
37. T cell response to N-formylated peptides in humans.
- Author
-
Ristori G, Montesperelli C, Fiorillo MT, Battistini L, Chersi A, Sorrentino R, Borsellino G, Perna A, Tramonti D, Cannoni S, Perrone MP, Giubilei F, Riccio P, Salvetti M, and Buttinelli C
- Subjects
- Adult, Amino Acid Sequence, Antigen Presentation, Cells, Cultured, Clone Cells, Female, Histocompatibility Antigens Class II immunology, Humans, Immunophenotyping, Interferon-gamma biosynthesis, Interleukin-4 biosynthesis, Lymphocyte Activation, Male, Middle Aged, Peptides chemical synthesis, Peptides chemistry, Receptors, Antigen, T-Cell genetics, T-Lymphocyte Subsets classification, CD4-Positive T-Lymphocytes immunology, N-Formylmethionine immunology, Peptides immunology
- Abstract
We present the first evidence of a T lymphocyte response to N-formylated peptides in humans. N-formylated peptide sequences from self (mitochondrial) and foreign (microbial) antigens were used to isolate antigen-specific T cell clones from healthy individuals, including a set of monozygotic twins. The observed response differed from that previously described in mouse (CD4(+) phenotype and MHC class II restriction in humans vs. CD8(+) phenotype and class I restriction in mice). These lymphocytes produce substantial amounts of IFN-gamma. They were isolated in only one of the monozygotic twins, which suggests that their expansion in the healthy immune repertoire is independent of the genetic background. Our result will help in assessing the relevance of N-formylated peptide-specific T cells in protection against infections within the human immune system.
- Published
- 2001
- Full Text
- View/download PDF
38. HLA-C and HLA-DQB1 compatibility in unrelated cord blood transplants.
- Author
-
Elia L, Arcese W, Torello M, Iori AP, Guglielmi C, Perrone MP, Screnci M, Sprovieri T, Rapanotti MC, and Cimino G
- Subjects
- Adolescent, Child, Child, Preschool, Female, Graft vs Host Disease epidemiology, Graft vs Host Disease etiology, HLA-C Antigens genetics, HLA-DQ Antigens genetics, HLA-DQ beta-Chains, Histocompatibility Testing, Humans, Male, Fetal Blood immunology, HLA-C Antigens blood, HLA-DQ Antigens blood, Hematopoietic Stem Cell Transplantation adverse effects, Histocompatibility immunology
- Abstract
Background and Objective: Umbilical cord blood (UCB) cells have been definitively proved to be a source of hematopoietic stem cells with repopulating capacity when transplanted into pediatric hosts with neoplastic or non-neoplastic disease. Moreover, due to the immaturity of the UCB lymphoid compartment, these transplants are usually associated with a low incidence and severity of GvHD. This clinical observation and the immaturity of the UCB lymphoid compartment justify the acceptance of UCB units which differ from their recipient by 1 or 2 HLA antigens of the six HLA A, B and DRB1 antigens conventionally typed. Whether the number and type of HLA disparities affect clinical outcome of UCB transplants has not, however, been clearly demonstrated yet., Design and Methods: In the present study on 14 pediatric patients with high risk leukemia transplanted with UCB from unrelated donors, evaluation of HLA compatibility was extended to HLA-C and DQB1 genes and correlated to the engraftment rate and occurrence of GvHD. Conditioning regimen and GvHD prophylaxis were identical in all cases. HLA-A and B antigens were typed by serology, whereas DNA based methods were used to define HLA-C gene groups, and HLA-DRB1 and DQB1 alleles., Results: Conventional HLA-A, B and DRB1 typing demonstrated that 12 recipient/donor pairs differed at one HLA locus, while 2 pairs had 2 HLA disparities. The extended HLA-typing showed that only one out of the six pairs with a different HLA-A locus had additional mismatches at HLA-C and DQB1 loci, whereas all the remaining 8 pairs, which already differed at HLA-B and/or DRB1 loci after conventional typing, had additional HLA-C and/or DQB1 mismatches (p = 0.002). By contrast, engraftment rate and occurrence of GvHD did not significantly correlate with level of HLA-mismatches even after extended HLA-typing., Interpretation and Conclusions: The present data show that additional mismatched HLA-C and/or DQB1 antigens are significantly more frequent in pairs which after conventional HLA-typing differed at HLA-B and/or DRB1 loci, than in those showing one HLA-A mismatch. This observation provides an additional criterion for selection of UCB donors with the closest HLA-match when more than one unit are available. We did not, however, observe any correlation between engraftment rate, occurrence of GvHD and degree of HLA disparities detected either by standard or extended typing. These data support the notion that certain HLA differences do not affect the clinical outcome of UCB transplants and indicate that the expensive and time consuming molecular typing of HLA-C and DQB1 loci might be avoided for UCB donor selection.
- Published
- 1999
39. HLA typing in hairy cell leukemia.
- Author
-
Annino L, Ferrari A, Laurenti L, Perrone MP, Romani C, Pacchiarotti A, Girelli G, and Mandelli F
- Subjects
- Adult, Aged, Female, HLA Antigens genetics, HLA-B Antigens analysis, HLA-B Antigens genetics, HLA-DR Antigens analysis, HLA-DR Antigens genetics, HLA-DR Serological Subtypes, Humans, Leukemia, Hairy Cell genetics, Male, Middle Aged, HLA Antigens analysis, Histocompatibility Testing, Leukemia, Hairy Cell immunology
- Abstract
In HCL patients some cases of familial occurrence of the disease were reported, without an association with a specific haplotype or HLA antigen. In a series of a non familial HCL patients an increase in DR11 frequency was reported. We performed HLA class I and class II antigens in a series of 38 consecutive HCL patients. An increased frequency of B17 (10/38-27%) and DR11 (22/38-57%) antigens compared with the normal Caucasian population was recorded. As clinical characteristics, no significant differences were recognized between DR11 positive and DR11 negative patients. In response to IFN treatment, a complete response (CR) was achieved in 20% of DR11 patients and in 46% of DR11 negative patients. In this study an increase frequency of B17 and DR11 antigens was found; furthermore DR11 positive patients seem to be less responsive to IFN treatment but a larger series of patients will have to be studied in the future in order to establish this observation with more certainty.
- Published
- 1994
40. Abnormal thyroid function test results in patients with Fisher-Evans syndrome.
- Author
-
Lio S, Albin M, Girelli G, Perrone MP, Gandolfo G, Conti L, Mazzone D, and D'Armiento M
- Subjects
- Adolescent, Adult, Aged, Anemia, Hemolytic, Autoimmune immunology, Anemia, Hemolytic, Autoimmune physiopathology, Autoantibodies blood, Child, Female, Humans, Male, Middle Aged, Purpura, Thrombocytopenic, Idiopathic immunology, Purpura, Thrombocytopenic, Idiopathic physiopathology, Syndrome, Thyroid Gland immunology, Thyroiditis, Autoimmune complications, Thyroiditis, Autoimmune immunology, Thyroiditis, Autoimmune pathology, Thyrotropin blood, Anemia, Hemolytic, Autoimmune complications, Purpura, Thrombocytopenic, Idiopathic complications, Thyroid Gland physiopathology
- Abstract
Thyroid function was evaluated in patients affected by Fisher-Evans syndrome (FES) and compared to that of patients affected only by autoimmune hemolytic anemia (AIHA) and to that of patients affected only by idiopathic thrombocytopenic purpura (ITP). The study population consisted of 20 patients with FES, 44 with AIHA and 20 with ITP. All patients were examined for thyroid function abnormalities and thyroid autoantibodies. Abnormal thyroid function test results were observed in 40, 25 and 10% of the patients, respectively. The prevalence of antithyroid antibodies (ATA) in FES was 25%; this is higher than the sum of the prevalences of ATA in patients affected only by AIHA (11.4%) or only by ITP (none). Subclinical primary hypothyroidism and hyperthyroxinemia with or without hypertriiodothyroninemia, with TSH serum levels below normal, were present in 20% and 10% of patients affected by FES, respectively. Of the former, 75% were positive for ATA. These results: i) confirm the high prevalence of abnormal thyroid test results in patients affected by AIHA, ITP and FES; ii) demonstrate the higher prevalence of autoimmune hypothyroidism in FES; iii) lead to the possibility of including FES as one of the multiple autoimmune syndromes.
- Published
- 1993
- Full Text
- View/download PDF
41. Anti-erythrocyte autoimmunization in hydatid disease.
- Author
-
Girelli G, Teggi A, Perrone MP, Di Vico B, Gandolfo GM, and De Rosa F
- Subjects
- Adolescent, Adult, Aged, Child, Echinococcosis complications, Echinococcosis, Hepatic complications, Female, Humans, Male, Middle Aged, Anemia, Hemolytic, Autoimmune complications, Autoantibodies blood, Echinococcosis immunology, Echinococcosis, Hepatic immunology, Erythrocytes immunology
- Abstract
A 73-year-old man with hydatid disease developed autoimmune hemolytic anemia due to IgM cold agglutinin with anti-I specificity. Hemolysis decreased after initiating mebendazole therapy. The cysts notably diminished in size and the red cell autoantibodies disappeared at the end of this treatment. On the basis of these observations, 44 patients with hydatid disease were investigated. One patient showed IgM cold autoantibody with no signs of anemia. In addition, cleavage fragments of C3 were detected on the erythrocyte membranes of 6 patients, following chronic activation of the complement system. We suggest that parasitic antigens may evoke antibodies cross-reacting with the red blood cells of the host.
- Published
- 1993
- Full Text
- View/download PDF
42. Hemolytic anemia and thrombocytopenia induced by cyanidanol.
- Author
-
Gandolfo GM, Girelli G, Conti L, Perrone MP, Arista MC, and Damico C
- Subjects
- Aged, Anemia, Hemolytic chemically induced, Autoantibodies blood, Blood Platelets immunology, Erythrocytes immunology, Female, Humans, Immunoglobulin G blood, Male, Middle Aged, Thrombocytopenia chemically induced, Anemia, Hemolytic immunology, Autoimmune Diseases chemically induced, Catechin adverse effects, Thrombocytopenia immunology
- Abstract
Five patients who received cyanidanol for 4-36 months are presented. Three developed both hemolytic anemia and thrombocytopenia, while 2 had only thrombocytopenia. After suspending the drug the hematological values returned to normal in all of the patients. Drug-dependent platelet antibodies were detected in 4 of the 5 patients and cyanidanol-dependent red blood cell antibodies were present in 3. There are various mechanisms involved in the cyanidanol-induced immune cytopenias and, as in the present study, were sometimes simultaneously observed in the same patient.
- Published
- 1992
- Full Text
- View/download PDF
43. A metastatic breast carcinoma presenting as autoimmune hemolytic anemia.
- Author
-
Adorno G, Girelli G, Perrone MP, Arista MC, Coluzzi S, Masi M, Giudiceandrea P, and Papa G
- Subjects
- Aged, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Breast Neoplasms drug therapy, Cyclophosphamide administration & dosage, Doxorubicin administration & dosage, Female, Fluorouracil administration & dosage, Humans, Neoplasm Recurrence, Local drug therapy, Anemia, Hemolytic, Autoimmune etiology, Breast Neoplasms complications, Neoplasm Recurrence, Local complications
- Abstract
The authors describe the case of a 75-year-old female who was hospitalized for anemia of unknown origin. Physical examination revealed a swelling in the right mammary region, where a mastectomy scar was present from surgery for a breast carcinoma. On admission, laboratory tests disclosed anemia (Hb, 8.5 g/dl), with a reticulocyte count of 65,000/mm3 and slightly increased bilirubin. Immunohematologic study revealed the presence of a red cell autoantibody with anti-D specificity in the serum and in the eluate from the patient's erythrocytes. A biopsy of the swelling was performed and histologic examination showed the presence of metastatic cells of breast carcinoma. The patient was given chemotherapy and radiotherapy. At this writing the anemia was absent, the immunohematologic study was negative, the swelling was greatly reduced, and no other metastatic lesions of breast carcinoma were present.
- Published
- 1991
- Full Text
- View/download PDF
44. A second example of hemolysis due to IgA autoantibody with anti-e specificity.
- Author
-
Girelli G, Perrone MP, Adorno G, Arista MC, Coluzzi S, Damico C, di Giorgio G, and Monarca B
- Subjects
- Adult, Coombs Test, Female, Humans, Anemia, Hemolytic, Autoimmune immunology, Antibody Specificity immunology, Autoantibodies immunology, Immunoglobulin A immunology, Rh-Hr Blood-Group System immunology
- Abstract
A case of warm autoimmune hemolytic anemia due to IgA antibody is described. The patient had clinical and hematologic signs of hyperhemolysis, but all specific tests were negative. The direct antiglobulin test was positive only when it was performed with anti-IgA monospecific antiserum. The autoantibody eluted from the patient's red cells showed anti-e specificity. The sensitivity of broad-spectrum antiglobulin serum and the possible hemolytic mechanisms of IgA-coated red cells are discussed.
- Published
- 1990
45. Thyroid functioning in autoimmune hemolytic anemias.
- Author
-
Girelli G, Lio S, Adorno G, Perrone MP, and D'Armiento M
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Anemia, Hemolytic, Autoimmune immunology, Autoantibodies immunology, Child, Female, Humans, Male, Middle Aged, Anemia, Hemolytic, Autoimmune complications, Hypothyroidism etiology, Thyroid Gland immunology
- Published
- 1986
- Full Text
- View/download PDF
46. Hemolysis in Rh-negative female recipient after Rh-incompatible bone marrow transplantation for chronic myeloid leukemia.
- Author
-
Girelli G, Arcese W, Bianchi A, Mauro FR, Malagnino F, Adorno G, Iurlo A, Perrone MP, and Papa G
- Subjects
- Adult, Female, Humans, Leukemia, Myeloid blood, Phenotype, Tissue Donors, Blood Group Incompatibility, Bone Marrow Transplantation, Hemolysis, Leukemia, Myeloid therapy, Rh-Hr Blood-Group System
- Published
- 1986
47. Kidney carcinoma revealed by autoimmune hemolytic anemia.
- Author
-
Girelli G, Adorno G, Perrone MP, Arista MC, Cardillo A, Vegna ML, Petti MC, and Mandelli F
- Subjects
- Adult, Humans, Male, Adenocarcinoma complications, Anemia, Hemolytic, Autoimmune etiology, Kidney Neoplasms complications
- Published
- 1988
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.